$ACON
Aclarion, Inc.

2024 Q4 Form 10-Q Financial Statement

#000168316824008063 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $14.41K
YoY Change -24.43%
Cost Of Revenue $21.33K
YoY Change 9.07%
Gross Profit -$6.925K
YoY Change 1304.67%
Gross Profit Margin -48.07%
Selling, General & Admin $1.093M
YoY Change 13.47%
% of Gross Profit
Research & Development $195.8K
YoY Change -1.24%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.289M
YoY Change 10.96%
Operating Profit -$1.296M
YoY Change 11.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$70.22K
YoY Change -142.77%
Pretax Income -$1.366M
YoY Change 36.89%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.366M
YoY Change 36.89%
Net Earnings / Revenue -9482.72%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$0.15
COMMON SHARES
Basic Shares Outstanding 10.43M shares 8.611M shares
Diluted Shares Outstanding 9.438M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.312M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $16.95K
Other Receivables
Total Short-Term Assets $1.897M
YoY Change 419.89%
LONG-TERM ASSETS
Property, Plant & Equipment $892.00
YoY Change -56.76%
Goodwill
YoY Change
Intangibles $1.290M
YoY Change 9.66%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.291M
YoY Change 9.54%
TOTAL ASSETS
Total Short-Term Assets $1.897M
Total Long-Term Assets $1.291M
Total Assets $3.188M
YoY Change 106.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $331.8K
YoY Change -51.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $678.3K
YoY Change -71.4%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $678.3K
Total Long-Term Liabilities
Total Liabilities $678.3K
YoY Change -71.38%
SHAREHOLDERS EQUITY
Retained Earnings -$49.27M
YoY Change 14.54%
Common Stock $100.00
YoY Change 21.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.510M
YoY Change
Total Liabilities & Shareholders Equity $3.188M
YoY Change 106.58%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.366M
YoY Change 36.89%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
ACLARION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Local Phone Number
LocalPhoneNumber
275-2266
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41358
dei Entity Address Address Line1
EntityAddressAddressLine1
8181 Arista Place
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1312098 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1021069 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
10000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
10000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16951 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13270 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
558272 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
245030 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1897321 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1289369 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
892 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1782 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1289839 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1168623 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1290731 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1170405 usd
CY2024Q3 us-gaap Assets
Assets
3188052 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
760535 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
330232 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
121326 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
678267 usd
CY2024Q3 us-gaap Liabilities
Liabilities
678267 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3187769 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10044728 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10044728 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
825459 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
825459 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
100 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001635077
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3324725
dei Entity Address City Or Town
EntityAddressCityOrTown
Broomfield
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80021
dei City Area Code
CityAreaCode
833
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10431159 shares
CY2023Q4 us-gaap Assets
Assets
2459774 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
331765 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
857722 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
0 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1125724 usd
CY2024Q3 ACON Warrant Liability Current
WarrantLiabilityCurrent
16270 usd
CY2023Q4 ACON Warrant Liability Current
WarrantLiabilityCurrent
289165 usd
CY2024Q3 ACON Liability To Issue Equity
LiabilityToIssueEquity
0 usd
CY2023Q4 ACON Liability To Issue Equity
LiabilityToIssueEquity
33297 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3187769 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51782424 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43553523 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49272739 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44281526 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2509785 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-727995 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3188052 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2459774 usd
CY2024Q3 us-gaap Revenues
Revenues
14407 usd
CY2023Q3 us-gaap Revenues
Revenues
19065 usd
us-gaap Revenues
Revenues
35492 usd
us-gaap Revenues
Revenues
61607 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
21332 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
19558 usd
us-gaap Cost Of Revenue
CostOfRevenue
64102 usd
us-gaap Cost Of Revenue
CostOfRevenue
56312 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
-6925 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-493 usd
us-gaap Gross Profit
GrossProfit
-28610 usd
us-gaap Gross Profit
GrossProfit
5295 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
232775 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
192896 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
638869 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
577969 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
195797 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
198252 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
636940 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
652657 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
860461 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
770534 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2402408 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2524308 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1289033 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1161682 usd
us-gaap Operating Expenses
OperatingExpenses
3678217 usd
us-gaap Operating Expenses
OperatingExpenses
3754934 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1295958 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1162175 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3706827 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3749640 usd
CY2024Q3 us-gaap Interest Expense Other
InterestExpenseOther
71527 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
166332 usd
us-gaap Interest Expense Other
InterestExpenseOther
535199 usd
us-gaap Interest Expense Other
InterestExpenseOther
214850 usd
CY2024Q3 ACON Loss On Exchange Of Debt
LossOnExchangeOfDebt
6585 usd
CY2023Q3 ACON Loss On Exchange Of Debt
LossOnExchangeOfDebt
-0 usd
ACON Loss On Exchange Of Debt
LossOnExchangeOfDebt
1073317 usd
ACON Loss On Exchange Of Debt
LossOnExchangeOfDebt
-0 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-111928 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7591 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
330252 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
330632 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
318452 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
303 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
245 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
93284 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70218 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
164165 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1296528 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
103613 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1366176 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-998010 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5003355 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3646027 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1366176 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-998010 usd
us-gaap Net Income Loss
NetIncomeLoss
-5003355 usd
us-gaap Net Income Loss
NetIncomeLoss
-3646027 usd
CY2024Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
12142 usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-0 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
12142 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-0 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1378318 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-998010 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5015497 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3646027 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.87
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.07
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9437871 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9437871 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
532928 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
532928 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7699173 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7699173 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
515975 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
515975 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2225958 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
82531 usd
CY2023Q1 ACON Proceeds From Sale Of Series Preferred Stock
ProceedsFromSaleOfSeriesPreferredStock
1000 usd
CY2023Q1 ACON Redemption Of Series Preferred Stock
RedemptionOfSeriesPreferredStock
-1000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1183460 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1125029 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
136631 usd
CY2023Q2 ACON Commitment Shares Note Financing
CommitmentSharesNoteFinancing
175619 usd
CY2023Q2 ACON Issuance Of Warrants Note Financing
IssuanceOfWarrantsNoteFinancing
37500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1464557 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10223 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
137307 usd
CY2023Q3 ACON Issuance Of Warrants Note Financing
IssuanceOfWarrantsNoteFinancing
22500 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-998010 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-827980 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-727995 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85827 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q1 ACON Issuance Of Common Shares Equity Line Of Credit
IssuanceOfCommonSharesEquityLineOfCredit
1449532 usd
CY2024Q1 ACON Issuance Of Commitment Shares Note Financing
IssuanceOfCommitmentSharesNoteFinancing
33297 usd
CY2024Q1 ACON Cashless Exercise Of Prefunded Warrant
CashlessExerciseOfPrefundedWarrant
0 usd
CY2024Q1 ACON Issuance Of Common Stock And Warrants Related To Public Offering Net Issuance Costs
IssuanceOfCommonStockAndWarrantsRelatedToPublicOfferingNetIssuanceCosts
2691391 usd
CY2024Q1 ACON Public Offering And Line Of Credit Issuance Costs
PublicOfferingAndLineOfCreditIssuanceCosts
-399106 usd
CY2024Q1 ACON Issuance Of Common Shares Debt For Equity Exchange
IssuanceOfCommonSharesDebtForEquityExchange
1771606 usd
CY2024Q1 ACON Round Up Conversion Related To Reverse Stock Split
RoundUpConversionRelatedToReverseStockSplit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2399102 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2505449 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
70305 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q2 ACON Issuance Of Common Shares Equity Line Of Credit
IssuanceOfCommonSharesEquityLineOfCredit
304500 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1238077 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1642177 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74706 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2024Q3 ACON Issuance Of Common Shares Related To Rega
IssuanceOfCommonSharesRelatedToRega
451971 usd
CY2024Q3 ACON Issuance Of Bseries Preferred Stock Debt For Equity Exchange
IssuanceOfBseriesPreferredStockDebtForEquityExchange
930052 usd
CY2024Q3 ACON Bseries Preferred Stock Issuance Costs
BseriesPreferredStockIssuanceCosts
-35000 usd
CY2024Q3 ACON Cseries Preferred Stock Issuance Costs
CseriesPreferredStockIssuanceCosts
-55000 usd
CY2024Q3 ACON Issuance Of Cseries Preferred Stock
IssuanceOfCseriesPreferredStock
602900 usd
CY2024Q3 ACON Common Stock Issuance Costs
CommonStockIssuanceCosts
-210228 usd
CY2024Q3 ACON Issuance Of Cseries Warrants
IssuanceOfCseriesWarrants
397100 usd
CY2024Q3 ACON Issuance Of Rega Warrants
IssuanceOfRegaWarrants
77283 usd
CY2024Q3 ACON Capitalization Of Bseries Preferred Stock Dividends
CapitalizationOfBseriesPreferredStockDividends
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1366176 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2509785 usd
us-gaap Net Income Loss
NetIncomeLoss
-5003355 usd
us-gaap Net Income Loss
NetIncomeLoss
-3646027 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
140893 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120886 usd
us-gaap Share Based Compensation
ShareBasedCompensation
230837 usd
us-gaap Share Based Compensation
ShareBasedCompensation
356469 usd
ACON Gain Loss On Exchange Of Debt
GainLossOnExchangeOfDebt
1073317 usd
ACON Gain Loss On Exchange Of Debt
GainLossOnExchangeOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-111928 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
502516 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
156159 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-330632 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-318452 usd
ACON Noncash Interest Related To Bridge Funding
NoncashInterestRelatedToBridgeFunding
58002 usd
ACON Noncash Interest Related To Bridge Funding
NoncashInterestRelatedToBridgeFunding
48954 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2351 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9409 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
329306 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-34182 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-443068 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
207771 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-326399 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
103695 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
52214 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
208857 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
208857 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
208857 usd
ACON Increase Decrease In Note Payable Net Of Discount
IncreaseDecreaseInNotePayableNetOfDiscount
-31129 usd
ACON Increase Decrease In Note Payable Net Of Discount
IncreaseDecreaseInNotePayableNetOfDiscount
32607 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4348748 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2913165 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
261220 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
85603 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261220 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85603 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2691391 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1754032 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
ACON Proceeds From Common Stock And Warrant Rega Offering
ProceedsFromCommonStockAndWarrantRegaOffering
529254 usd
ACON Proceeds From Common Stock And Warrant Rega Offering
ProceedsFromCommonStockAndWarrantRegaOffering
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
1000000 usd
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
300973 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
ACON Common Stock Cash Issuance Costs
CommonStockCashIssuanceCosts
714332 usd
ACON Common Stock Cash Issuance Costs
CommonStockCashIssuanceCosts
-0 usd
ACON Preferred Stock Cash Issuance Costs
PreferredStockCashIssuanceCosts
35000 usd
ACON Preferred Stock Cash Issuance Costs
PreferredStockCashIssuanceCosts
-0 usd
ACON Bridge Funding Issuance Costs
BridgeFundingIssuanceCosts
23375 usd
ACON Bridge Funding Issuance Costs
BridgeFundingIssuanceCosts
312588 usd
ACON Proceeds From Bridge Funding
ProceedsFromBridgeFunding
0 usd
ACON Proceeds From Bridge Funding
ProceedsFromBridgeFunding
2000000 usd
ACON Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
0 usd
ACON Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
1000 usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
-0 usd
us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
1000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4900996 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1687412 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
291028 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1311356 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1031069 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1482806 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1322098 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171450 usd
ACON Dividends Accrued On Preferred Shares
DividendsAccruedOnPreferredShares
12142 usd
ACON Dividends Accrued On Preferred Shares
DividendsAccruedOnPreferredShares
0 usd
ACON Exchange Of Indebtedness For Preferred Shares
ExchangeOfIndebtednessForPreferredShares
930052 usd
ACON Exchange Of Indebtedness For Preferred Shares
ExchangeOfIndebtednessForPreferredShares
0 usd
ACON Issuance Of Common Shares In Exchange For Debt
IssuanceOfCommonSharesInExchangeForDebt
1771606 usd
ACON Issuance Of Common Shares In Exchange For Debt
IssuanceOfCommonSharesInExchangeForDebt
0 usd
ACON Issuance Of Bridge Fund Commitment Shares
IssuanceOfBridgeFundCommitmentShares
33297 usd
ACON Issuance Of Bridge Fund Commitment Shares
IssuanceOfBridgeFundCommitmentShares
0 usd
ACON Accrued Issuance Costs Related To Preferred Stock
AccruedIssuanceCostsRelatedToPreferredStock
55000 usd
ACON Accrued Issuance Costs Related To Preferred Stock
AccruedIssuanceCostsRelatedToPreferredStock
0 usd
ACON Accrued Issuance Costs Related To Common Stock
AccruedIssuanceCostsRelatedToCommonStock
94733 usd
ACON Accrued Issuance Costs Related To Common Stock
AccruedIssuanceCostsRelatedToCommonStock
0 usd
ACON Designation Of Prepaid Expenses To Common Stock Issuance Costs
DesignationOfPrepaidExpensesToCommonStockIssuanceCosts
919439 usd
ACON Designation Of Prepaid Expenses To Common Stock Issuance Costs
DesignationOfPrepaidExpensesToCommonStockIssuanceCosts
0 usd
ACON Issuance Of Common Shares Related To Restricted Stock Units
IssuanceOfCommonSharesRelatedToRestrictedStockUnits
216397 usd
ACON Issuance Of Common Shares Related To Restricted Stock Units
IssuanceOfCommonSharesRelatedToRestrictedStockUnits
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
611054 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1289839 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60226 usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
60226 usd
ACON Fair Value Of Warrants And Derivative Related To Bridge Funding
FairValueOfWarrantsAndDerivativeRelatedToBridgeFunding
0 usd
ACON Fair Value Of Warrants And Derivative Related To Bridge Funding
FairValueOfWarrantsAndDerivativeRelatedToBridgeFunding
896798 usd
ACON Accrued Debt Issuance Costs Related To Bridge Funding
AccruedDebtIssuanceCostsRelatedToBridgeFunding
0 usd
ACON Accrued Debt Issuance Costs Related To Bridge Funding
AccruedDebtIssuanceCostsRelatedToBridgeFunding
16225 usd
ACON Issuance Of Warrants Related To Bridge Funding
IssuanceOfWarrantsRelatedToBridgeFunding
0 usd
ACON Issuance Of Warrants Related To Bridge Funding
IssuanceOfWarrantsRelatedToBridgeFunding
60000 usd
ACON Issuance Of Commitment Shares Related To Bridge Funding
IssuanceOfCommitmentSharesRelatedToBridgeFunding
0 usd
ACON Issuance Of Commitment Shares Related To Bridge Funding
IssuanceOfCommitmentSharesRelatedToBridgeFunding
175619 usd
ACON Original Issue Discount15 Related To Bridge Funding
OriginalIssueDiscount15RelatedToBridgeFunding
0 usd
ACON Original Issue Discount15 Related To Bridge Funding
OriginalIssueDiscount15RelatedToBridgeFunding
300000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_ze4dymL918a1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zzLYxXBXIvN6">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to depreciation, amortization, and valuation of warrants, warrant and derivative liabilities, and options to purchase shares of the Company's common stock. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_845_eus-gaap--DerivativesReportingOfDerivativeActivity_zsxi2kHK9qN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86B_zmjFLxJt3DGj">Derivative Financial Instruments</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has derivative financial instruments that are not hedges and do not qualify for hedge accounting. Changes in the fair value of these instruments are recorded in other income (expenses), on a net basis in the Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
973093 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
761800 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
10000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
2594118 usd
CY2024Q3 ACON Unamortized Discounts And Deferred Financing Costs Warrants
UnamortizedDiscountsAndDeferredFinancingCostsWarrants
0 usd
CY2023Q4 ACON Unamortized Discounts And Deferred Financing Costs Warrants
UnamortizedDiscountsAndDeferredFinancingCostsWarrants
-557582 usd
CY2024Q3 ACON Unamortized Discounts And Deferred Financing Costs Derivative
UnamortizedDiscountsAndDeferredFinancingCostsDerivative
0 usd
CY2023Q4 ACON Unamortized Discounts And Deferred Financing Costs Derivative
UnamortizedDiscountsAndDeferredFinancingCostsDerivative
-235628 usd
CY2024Q3 ACON Unamortized Discounts And Deferred Financing Costs Issuance Cost
UnamortizedDiscountsAndDeferredFinancingCostsIssuanceCost
0 usd
CY2023Q4 ACON Unamortized Discounts And Deferred Financing Costs Issuance Cost
UnamortizedDiscountsAndDeferredFinancingCostsIssuanceCost
-675184 usd
CY2024Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
16270 usd
CY2024Q3 ACON Unamortized Discounts And Deferred Financing Costs Total
UnamortizedDiscountsAndDeferredFinancingCostsTotal
0 usd
CY2023Q4 ACON Unamortized Discounts And Deferred Financing Costs Total
UnamortizedDiscountsAndDeferredFinancingCostsTotal
-1468394 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
0 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1125724 usd
CY2023Q4 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
410491 usd
ACON Exchange And Payoff Of Notes Payable
ExchangeAndPayoffOfNotesPayable
-63589 usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-330632 usd
CY2024Q3 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
16270 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
558272 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
245030 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
331765 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
760535 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
330232 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
857722 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2533487 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2272268 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-1243648 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-1103645 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1289839 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1168623 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
49732 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40797 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
140003 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
119602 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10044728 shares
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1378318 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-998010 usd
CY2024Q3 ACON Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
9430357 shares
CY2023Q3 ACON Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
513172 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7514 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
19756 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9437871 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9437871 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
532928 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
532928 shares
us-gaap Profit Loss
ProfitLoss
-5015497 usd
us-gaap Profit Loss
ProfitLoss
-3646027 usd
ACON Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
7688398 shares
ACON Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
503334 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10775 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12642 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7699173 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7699173 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
515975 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
515975 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11939563 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7328736 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
169456 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.15
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
169456 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
147977 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
158468 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
74706 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
137307 usd
us-gaap Share Based Compensation
ShareBasedCompensation
230837 usd
us-gaap Share Based Compensation
ShareBasedCompensation
356469 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008063-index-headers.html Edgar Link pending
0001683168-24-008063-index.html Edgar Link pending
0001683168-24-008063.txt Edgar Link pending
0001683168-24-008063-xbrl.zip Edgar Link pending
aclarion_ex3101.htm Edgar Link pending
aclarion_ex3102.htm Edgar Link pending
aclarion_ex3201.htm Edgar Link pending
aclarion_ex3202.htm Edgar Link pending
aclarion_i10q-093024.htm Edgar Link pending
acon-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
acon-20240930_cal.xml Edgar Link unprocessable
acon-20240930_def.xml Edgar Link unprocessable
acon-20240930_lab.xml Edgar Link unprocessable
acon-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aclarion_i10q-093024_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending